Literature DB >> 18487282

Association between ESR2 genetic variants and risk of myocardial infarction.

Sophie Domingues-Montanari1, Isaac Subirana, Marta Tomás, Jaume Marrugat, Mariano Sentí.   

Abstract

BACKGROUND: Environmental and genetic factors contribute to the development of complex diseases such as myocardial infarction (MI), the leading cause of death in men and women. Women develop MI approximately 10 years later than men, a difference that could be explained by the genes coding for the estrogen receptors. Single nucleotide polymorphisms (SNPs) in the ESR2 gene may affect susceptibility for MI in a sex-dependent manner.
METHODS: A nested case-control design was used to analyze 3 polymorphisms of the ESR2 gene and their associated haplotypes in 710 myocardial infarction cases from the REGICOR (Registre Gironí del Corazón) study and 2379 controls randomly selected in a representative population of a Spanish cross-sectional study.
RESULTS: The rs1271572 T allele was significantly more common in patients who developed MI (P < 0.001). No association was observed for rs1256049 or rs4986938. Assuming a dominant model of inheritance, the association, as determined by logistic multivariate regression after adjustment for conventional cardiac risk factors, remained statistically significant in men [odds ratio (OR) 1.65, 95% CI 1.18-2.30; P = 0.003) but not in women (P = 0.754). A very common haplotype encompassing the rs1271572 variant was also associated with the risk of MI in the overall population (OR 1.41, 95% CI 1.06-1.87; P = 0.020) and in men (OR 1.57, 95% CI 1.12-2.21; P = 0.009).
CONCLUSIONS: The rs1271572 SNP T variant was associated with increased risk of MI in a Spanish population, and this association was found to be limited to men only. Sex differences in the genetic risk merit further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487282     DOI: 10.1373/clinchem.2007.102400

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

Review 1.  The Role of Estrogen and Estrogen Receptors on Cardiomyocytes: An Overview.

Authors:  Tao Luo; Jin Kyung Kim
Journal:  Can J Cardiol       Date:  2015-11-02       Impact factor: 5.223

Review 2.  The effects of oestrogens and their receptors on cardiometabolic health.

Authors:  Eugenia Morselli; Roberta S Santos; Alfredo Criollo; Michael D Nelson; Biff F Palmer; Deborah J Clegg
Journal:  Nat Rev Endocrinol       Date:  2017-03-17       Impact factor: 43.330

3.  Single nucleotide polymorphisms of ERβ and coronary atherosclerotic disease in Chinese Han women.

Authors:  Chunyu Shen; Zhenglian Chen; Mohammed Mahmoodurrahman; Xinshan Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  Gender differences in cardiovascular disease: hormonal and biochemical influences.

Authors:  Faustino R Pérez-López; Luis Larrad-Mur; Amanda Kallen; Peter Chedraui; Hugh S Taylor
Journal:  Reprod Sci       Date:  2010-06       Impact factor: 3.060

5.  Functional characterization of a genetic polymorphism in the promoter of the ESR2 gene.

Authors:  Santosh Philips; Alexandra Richter; Steffi Oesterreich; James M Rae; David A Flockhart; Narayanan B Perumal; Todd C Skaar
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

6.  Genetic Predictors of Salt Sensitivity of Blood Pressure: The Additive Impact of 2 Hits in the Same Biological Pathway.

Authors:  Andrea V Haas; Li En Yee; Yan E Yuan; Yin H Wong; Paul N Hopkins; Xavier Jeunemaitre; Jessica Lasky-Su; Jonathan S Williams; Gail K Adler; Gordon H Williams
Journal:  Hypertension       Date:  2021-11-10       Impact factor: 10.190

Review 7.  Polymorphisms of estrogen receptors and risk of depression: therapeutic implications.

Authors:  Joanne Ryan; Marie-Laure Ancelin
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

8.  The association between estrogen receptor 2 gene polymorphism and complexity of coronary artery disease: an analysis in elective percutaneous coronary intervention patients.

Authors:  Farzaneh Foroughinia; Pooyan Dehghani; Mehdi Dianatpour; Arghavan Amiri; Iman Jamhiri; Parisa Ghasemiyeh
Journal:  BMC Cardiovasc Disord       Date:  2021-06-04       Impact factor: 2.298

9.  Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort study.

Authors:  Joanne Ryan; Marianne Canonico; Laure Carcaillon; Isabelle Carrière; Jacqueline Scali; Jean-Francois Dartigues; Carole Dufouil; Karen Ritchie; Pierre-Yves Scarabin; Marie-Laure Ancelin
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

10.  Adjuvant chemotherapy-associated lipid changes in breast cancer patients: A real-word retrospective analysis.

Authors:  Tao He; Chengshi Wang; Qiuwen Tan; Zhu Wang; Jiayuan Li; Tao Chen; Kaijun Cui; Yunhao Wu; Jiani Sun; Danxi Zheng; Qing Lv; Jie Chen
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.